Literature DB >> 52287

Treatment of Whipple's disease with sulphamethoxazole-trimethoprim.

L Elsborg, E Gravgaard, N O Jacobsen.   

Abstract

A patient with Whipple's disease responding rapidly to sulphamethoxazole-trimethoprim is described. In spite of initial folate deficiency, the drug was well tolerated for one year. It is proposed that a sulphonamide combined with trimethoprim should be the drug of first choice in the treatment of Whipple's disease. Repeated jejunal biopsy is suggested as the best way to record the effectiveness of treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52287     DOI: 10.1111/j.0954-6820.1975.tb19519.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

1.  Whipple's Disease.

Authors:  Klaus Mönkemüller; Lucía C Fry; Steffen Rickes; Peter Malfertheiner
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

2.  Is there an immune deficit in Whipple's disease?

Authors:  W O Dobbins
Journal:  Dig Dis Sci       Date:  1981-03       Impact factor: 3.199

3.  An evaluation of antimicrobial treatment for Whipple's Disease. Tetracycline versus trimethoprim-sulfamethoxazole.

Authors:  G E Feurle; T Marth
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

4.  Whipple's disease in a female with impaired cell-mediated immunity unresponsive to co-trimoxazole and levamisole therapy.

Authors:  M R Haeney; I N Ross
Journal:  Postgrad Med J       Date:  1978-01       Impact factor: 2.401

Review 5.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.